110 related articles for article (PubMed ID: 21084279)
1. BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.
Wang HF; Takenaka K; Nakanishi A; Miki Y
Cancer Res; 2011 Jan; 71(1):68-77. PubMed ID: 21084279
[TBL] [Abstract][Full Text] [Related]
2. Functional relationship among PLK2, PLK4 and ROCK2 to induce centrosome amplification.
Ling H; Hanashiro K; Luong TH; Benavides L; Fukasawa K
Cell Cycle; 2015; 14(4):544-53. PubMed ID: 25590559
[TBL] [Abstract][Full Text] [Related]
3. A CRM1-mediated nuclear export signal governs cytoplasmic localization of BRCA2 and is essential for centrosomal localization of BRCA2.
Han X; Saito H; Miki Y; Nakanishi A
Oncogene; 2008 May; 27(21):2969-77. PubMed ID: 18059333
[TBL] [Abstract][Full Text] [Related]
4. Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication.
Ma Z; Kanai M; Kawamura K; Kaibuchi K; Ye K; Fukasawa K
Mol Cell Biol; 2006 Dec; 26(23):9016-34. PubMed ID: 17015463
[TBL] [Abstract][Full Text] [Related]
5. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication.
Wang W; Budhu A; Forgues M; Wang XW
Nat Cell Biol; 2005 Aug; 7(8):823-30. PubMed ID: 16041368
[TBL] [Abstract][Full Text] [Related]
6. BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization.
Niwa T; Saito H; Imajoh-ohmi S; Kaminishi M; Seto Y; Miki Y; Nakanishi A
Cancer Sci; 2009 Nov; 100(11):2115-25. PubMed ID: 19709076
[TBL] [Abstract][Full Text] [Related]
7. Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division.
Nakanishi A; Han X; Saito H; Taguchi K; Ohta Y; Imajoh-Ohmi S; Miki Y
Biochem Biophys Res Commun; 2007 Mar; 355(1):34-40. PubMed ID: 17286961
[TBL] [Abstract][Full Text] [Related]
8. The role of nucleophosmin in centrosome duplication.
Okuda M
Oncogene; 2002 Sep; 21(40):6170-4. PubMed ID: 12214246
[TBL] [Abstract][Full Text] [Related]
9. WTIP interacts with BRCA2 and is essential for BRCA2 centrosome localization in cervical cancer cell.
Zhang J; Xu J; Wang G; Sun P; Yan T; Zhao X
Arch Gynecol Obstet; 2016 Nov; 294(6):1311-1316. PubMed ID: 27535760
[TBL] [Abstract][Full Text] [Related]
10. Aberrant activation of cell cycle regulators, centrosome amplification, and mitotic defects.
Fukasawa K
Horm Cancer; 2011 Apr; 2(2):104-12. PubMed ID: 21761333
[TBL] [Abstract][Full Text] [Related]
11. Centrosomal BRCA2 is a target protein of membrane type-1 matrix metalloproteinase (MT1-MMP).
Wali N; Hosokawa K; Malik S; Saito H; Miyaguchi K; Imajoh-Ohmi S; Miki Y; Nakanishi A
Biochem Biophys Res Commun; 2014 Jan; 443(4):1148-54. PubMed ID: 24384087
[TBL] [Abstract][Full Text] [Related]
12. Activated ROCK II by-passes the requirement of the CDK2 activity for centrosome duplication and amplification.
Hanashiro K; Brancaccio M; Fukasawa K
Oncogene; 2011 May; 30(19):2188-97. PubMed ID: 21242972
[TBL] [Abstract][Full Text] [Related]
13. Nucleophosmin and human cancer.
Lim MJ; Wang XW
Cancer Detect Prev; 2006; 30(6):481-90. PubMed ID: 17113241
[TBL] [Abstract][Full Text] [Related]
14. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2.
Daniels MJ; Wang Y; Lee M; Venkitaraman AR
Science; 2004 Oct; 306(5697):876-9. PubMed ID: 15375219
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation regulates nucleophosmin targeting to the centrosome during mitosis as detected by cross-reactive phosphorylation-specific MKK1/MKK2 antibodies.
Cha H; Hancock C; Dangi S; Maiguel D; Carrier F; Shapiro P
Biochem J; 2004 Mar; 378(Pt 3):857-65. PubMed ID: 14670079
[TBL] [Abstract][Full Text] [Related]
16. Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2.
Hussain S; Wilson JB; Blom E; Thompson LH; Sung P; Gordon SM; Kupfer GM; Joenje H; Mathew CG; Jones NJ
DNA Repair (Amst); 2006 May; 5(5):629-40. PubMed ID: 16621732
[TBL] [Abstract][Full Text] [Related]
17. BRCA2 mediates centrosome cohesion via an interaction with cytoplasmic dynein.
Malik S; Saito H; Takaoka M; Miki Y; Nakanishi A
Cell Cycle; 2016 Aug; 15(16):2145-2156. PubMed ID: 27433848
[TBL] [Abstract][Full Text] [Related]
18. Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.
Wu K; Hinson SR; Ohashi A; Farrugia D; Wendt P; Tavtigian SV; Deffenbaugh A; Goldgar D; Couch FJ
Cancer Res; 2005 Jan; 65(2):417-26. PubMed ID: 15695382
[TBL] [Abstract][Full Text] [Related]
19. BRCA2 suppresses cell proliferation via stabilizing MAGE-D1.
Tian XX; Rai D; Li J; Zou C; Bai Y; Wazer D; Band V; Gao Q
Cancer Res; 2005 Jun; 65(11):4747-53. PubMed ID: 15930293
[TBL] [Abstract][Full Text] [Related]
20. Novel BRCA2-interacting protein BJ-HCC-20A inhibits the induction of apoptosis in response to DNA damage.
Tomiyoshi G; Nakanishi A; Takenaka K; Yoshida K; Miki Y
Cancer Sci; 2008 Apr; 99(4):747-54. PubMed ID: 18307534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
